{"id":"W4402567816","doi":"10.1080/14796694.2024.2394323","title":"A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma","year":2024,"lang":"en","type":"article","venue":"Future Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"Janssen Biotech; Sanofi Pasteur; AbbVie Biotherapeutics; Regeneron Pharmaceuticals; Karyopharm Therapeutics; Janssen Pharmaceuticals; Celgene; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Daratumumab; Lenalidomide; Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01081937,0.00132972,0.002554507,0.002521506,0.000692882,0.002835963,0.001032125,0.001434261,0.03476392],"category_scores_gemma":[0.03662952,0.0006707352,0.002624873,0.003165819,0.000323895,0.001256173,0.0009468429,0.002438661,0.007624247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00184018,"about_ca_system_score_gemma":0.005195844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005603124,"about_ca_topic_score_gemma":0.007014043,"domain_scores_codex":[0.9914703,0.004422222,0.002162566,0.0004777829,0.00117836,0.0002887406],"domain_scores_gemma":[0.9704193,0.01695949,0.004261295,0.0005576545,0.006499122,0.001303167],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006049925,0.0002770842,0.003643258,0.03212259,0.002165349,0.000208695,0.0003144869,0.0001726918,0.0002740661,0.0008597325,0.8620388,0.09187339],"study_design_scores_gemma":[0.009014205,0.003084587,0.02766711,0.0495865,0.004971681,0.0004205874,0.0005973014,0.0001444067,0.0003361261,0.001642131,0.9023087,0.0002266821],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.0126677,0.4863979,0.003789359,0.1431009,0.04713622,0.009798813,0.2444808,0.0005908333,0.05203752],"genre_scores_gemma":[0.05640814,0.4472972,0.01060992,0.2112763,0.06601716,0.03209322,0.123619,0.0007426738,0.05193649],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03476392,"threshold_uncertainty_score":0.1162969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02224847335936487,"score_gpt":0.3427893113820992,"score_spread":0.3205408380227343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}